Close Menu

Scott Gottlieb, the former commissioner of the US Food and Drug Administration who resigned as head of the agency in April, has gone back to his old job: he has been rehired at the venture capital firm New Enterprise Associates (NEA) as a special partner on its healthcare investment team, according to MedCity News. Gottlieb had previously served as venture partner at NEA from 2007 until 2017, when he was appointed as FDA commissioner.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.